69 related articles for article (PubMed ID: 2252755)
1. Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients.
Di Paolo B; Del Rosso G; Catucci G; Vocino V; Terenzio MG; Bonomini M; Suriani K; Albertazzi A
ASAIO Trans; 1990; 36(3):M578-80. PubMed ID: 2252755
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur Heart J; 1988 May; 9(5):541-51. PubMed ID: 3402470
[TBL] [Abstract][Full Text] [Related]
3. The effect of simvastatin on dyslipemia in continuous ambulatory peritoneal dialysis patients.
Dimitriadis A; Antoniou S; Hatzisavvas N; Pastore F; Kaldi I; Stangou M
Perit Dial Int; 1993; 13 Suppl 2():S434-6. PubMed ID: 8399633
[TBL] [Abstract][Full Text] [Related]
4. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients.
Wanner C; Lubrich-Birkner I; Summ O; Wieland H; Schollmeyer P
Nephron; 1992; 62(1):40-6. PubMed ID: 1436290
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M
Adv Perit Dial; 2010; 26():53-7. PubMed ID: 21348380
[TBL] [Abstract][Full Text] [Related]
9. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
[TBL] [Abstract][Full Text] [Related]
10. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
[TBL] [Abstract][Full Text] [Related]
11. Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients.
Matthys E; Schurgers M; Lamberigts G; Lameire N; Vandecasteele N; Labeur C; Beisiegel U; Rosseneu M
Atherosclerosis; 1991 Feb; 86(2-3):183-92. PubMed ID: 1872912
[TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
Ide H; Fujiya S; Aanuma Y; Agishi Y
Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
[TBL] [Abstract][Full Text] [Related]
13. Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group.
Walker RJ; Sutherland WH; Walker HL; MacMahon S; Robson RA
Nephrol Dial Transplant; 1997 Jan; 12(1):87-92. PubMed ID: 9027779
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin in CAPD patients with hypercholesterolemia.
De Vecchi A; Scalamogna A; Paparella M; Colombini M; Rovellini A; Pini C; Castelnovo C
Adv Perit Dial; 1992; 8():331-3. PubMed ID: 1361817
[TBL] [Abstract][Full Text] [Related]
15. Effect of simvastatin on the lipid profile of hemodialysis patients.
Nishikawa O; Mune M; Miyano M; Nishide T; Nishide I; Maeda A; Kimura K; Takahashi T; Kishino M; Tone Y; Otani H; Ogawa A; Maeda T; Yukawa S
Kidney Int Suppl; 1999 Jul; 71():S219-21. PubMed ID: 10412781
[TBL] [Abstract][Full Text] [Related]
16. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis.
Wanner C; Hörl WH; Luley CH; Wieland H
Kidney Int; 1991 Apr; 39(4):754-60. PubMed ID: 2051734
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P
Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355
[TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group.
Robson R; Collins J; Johnson R; Kitching R; Searle M; Walker R; Douglas J; Leary J; Whalley G; Sharpe N; MacMahon S
J Nephrol; 1997; 10(1):33-40. PubMed ID: 9241623
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
20. [Effects on simvastatin in continuous ambulatory peritoneal dialysis patients with hyperlipidemia].
Zhu XP; Li J; Liu FY; Liu YH
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):154-6. PubMed ID: 12212206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
